A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Clinical trial NCT06789172 · RECRUITING

Trial details

NCT number: NCT06789172
Sponsor: Epkin
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumours Sarcoma HNSCC Non Small Cell Lung Cancer NSCLC Colorectal Cancer (CRC)Myxofibrosarcoma (MFS)Solitary Fibrous Tumors Dedifferentiated Liposarcoma Undifferentiated Pleomorphic Sarcoma (UPS)Leiomyosarcoma Leiomyosarcoma (LMS)

Start date: 2025-01-23
Primary completion: 2028-07-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.